期刊文献+

A型肉毒毒素治疗皱眉纹疗效的影响因素分析 被引量:1

The impact factors of botulinum toxin type A in the treatment of glabellar lines
下载PDF
导出
摘要 目的:分析接受A型肉毒毒素(保妥适^(?))治疗皱眉纹患者的有效性,以及年龄、性别和皱纹程度对疗效的影响。方法:对170例尽力皱眉时皱眉纹的严重程度为中、重度的患者单次注射保妥适^(?)20U,在注射前,注射后7、30、60、90、120 d进行疗效评价。疗效评价指标包括研究者对患者尽力皱眉时和平静时皱眉纹的严重程度评分;患者对治疗后皱眉纹改善的总体评估;患者治疗后对自身年龄的评估。结果:20U的A型肉毒毒素注射治疗皱眉纹,注射后30 d,主要疗效标准有效率为94.12%,120d仍有52.94%的患者有效。影响疗效因素分析结果显示女性效果好于男性;平静状态时皱眉纹评分越低者效果越好;年龄对于疗效影响相对轻微;尽力皱眉状态下皱眉纹程度越重的患者可能注射后改善越明显,但中度患者在治疗后100%可以将皱眉纹程度改善到轻度或没有皱纹。结论:20 U的A型肉毒毒素注射治疗65岁以下中国人皱眉纹非常有效。男性患者可能需要酌情增加剂量:如果平静状态时皱眉纹评分为重度的患者建议联合其他治疗来提高疗效。 Objectives:To evaluate the efficacy of botulinum toxin type A (BoNTA) in the treatment of glabellar lines and the impact of age, gender and severity of wrinkles on the effect. Methods: A total of 170 subjects received a single treatment of BoNTA (20 U) and were followed on 7,30,60,90 and 120 clays after injection. Effective outcome measures included the investigator' rating of wrinkle severity at maximum frown and rest and the subjects'global assessment and self-perception of age. Results: The primary time point was the investigator' rating of glabellar line severity at maximum frown at day 30. The responder rate was 94.12% at day 30 and 52.94% at day 120. Assessment of impact factors showed that females had better result compared with male subjects. The subjects had milder wrinkle at rest response better to the treatment. Age of the subject had less impact on the result. The subjects had more severe wrinkle at maximum frown may improve more dramatically after the treatment, but 100% of the subjects with moderate wrinkle at maximum frown had no or mild wrinkle after the treatment. Conclusion: A single treatment with 20 U of BoNTA is effective in reducing glabellar lines in Chinese subjects aged less than 65. Male subjects may need a higher dosage. Combine with other therapy will increase the efficacy in subjects with severe glabellar lines at rest.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2010年第10期661-664,共4页 Journal of Clinical Dermatology
基金 葛兰素公司资助
关键词 皱眉纹 肉毒毒素 A型 glabellar line botulinum toxin, type A
  • 相关文献

参考文献13

  • 1Prystowsky JH,Siegel DM.Anatomy of Facial Lines and Wrinkles[M].//Blitzer A,et al.Management of Facial Lines and Wrinkles.Philadelphia:Lippincott Williams & Wilkins,2000:1-7.
  • 2Carruthers JD,Carruthers JA.Treatment of glabellar frown lines with C.botulinum-A exotoxin[J].J Dermatol Surg Oncol,1992,18(1):17-21.
  • 3吴艳,朱学骏.A型肉毒毒素在面部除皱方面的应用[J].中国麻风皮肤病杂志,2003,19(5):466-468. 被引量:4
  • 4虞瑞尧.A型肉毒毒素在美容皮肤科的应用[J].临床皮肤科杂志,2005,34(12):858-860. 被引量:6
  • 5de Maio M.The minimal approach:an innovation in facial cosmetic procedures[J].Aesthetic Plast Surg,2004,28(5):295-300.
  • 6Bosniak S,Cantisano-Zilkha M,Purewal BK,et al.Combination therapies in oculofacial rejuvenation[J].Orbit,2006,25(4):319-326.
  • 7Carruthers JA,Lowe N J,Menter MA,et al.A multicenter,double-blind,randomized,placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines[J].J Am Acad Dermatol,2002,46(6):840-849.
  • 8Carruthers JD,Lowe NJ,Menter MA,et al.Double-blind,placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines[J].Plast Reconstr Surg,2003,112(4):1089-1098.
  • 9Harii K,Kawashima M.A double-blind,randomized,placebocontrolled,two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects[J].Aesthetic Plast Surg,2008,32(5):724-730.
  • 10Carruthers J,Carruthers A.A prospective,randomized,parallel group study analyzing the effect of BTX-A(Botox)and nonanimal sourced hyaluronic acid(NASHA,Restylane)in combination compared with NASHA(Restylane)alone in severe glabellar rhytides in adult female subjects:treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTXA[J].Dermatol Surg,2003,29(8):802-809.

二级参考文献18

  • 1Benedetto AB. Botulinum toxin treatments of the upper half of the face[A]. Chinese Medical Association: Ⅸ Intematinal Congress of Dermatology[C]. Beijing, 2004. 136-137.
  • 2Benedetto AV. Cosmetic uses for botulinum toxin[A]. In: Thiers BH. Year Book of Dermatology and Dermatologic Surgury [M].Philadelphia: Mosby, 2003. 27-77.
  • 3Benedetto AV. The cosmetic uses of Botulinum toxin type A[J].Int J Dermatol, 1999, 38(9): 641-655.
  • 4Atamoros FP. Botulinum toxin in the Lower one third of the face [A]. Chinese Medical Association: Ⅸ International Congress of Dermatology[C]. Abstracts. Beijing, 2004. 137.
  • 5Brandt FS, Boker A. Botulinum toxin for rejuvenation of the neck [J]. Clin Dermatol, 2003, 21(6): 513-520.
  • 6Becker-Wegerich PM, Rauch L, Ruzicka T. Botulinum toxin A:successful decollete rejuvenation[J]. Dermatol Surg, 2002, 28(2):168-171.
  • 7Heckmann M, Ceballos-Baumann AO, Plewig G, et al. Botulinum toxin A for axillary hyperhidrosis (excessive sweating)[J]. N Engl J Med, 2001, 344(7): 488-493.
  • 8Zimbler MS, Holds JB, Kokoska MS, et al.Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast Surg 2001;3:165- 169.
  • 9Markey AC. Botulinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol 2000;25:173 - 175.
  • 10Gartland MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (BOTOX): degradation impotency with storage.Otolaryngol Head Neck Surg 1993; 108:135-140.

共引文献8

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部